116 related articles for article (PubMed ID: 38872859)
1. Biological effect of ETV4 and the underlying mechanism of its regulatory effect on epithelial‑mesenchymal transition in intrahepatic cholangiocarcinoma cells.
Liu L; Feng Y; Xiang X; Xu M; Tang G
Oncol Lett; 2024 Aug; 28(2):346. PubMed ID: 38872859
[TBL] [Abstract][Full Text] [Related]
2. ETV4 promotes the progression of cholangiocarcinoma by regulating glycolysis via the TGF-β signaling.
Liu F; Wang Q; Wang Z; Zhang S; Ni Q; Chang H
Transl Oncol; 2024 Jun; 47():102035. PubMed ID: 38878613
[TBL] [Abstract][Full Text] [Related]
3. FXR Acts as a Metastasis Suppressor in Intrahepatic Cholangiocarcinoma by Inhibiting IL-6-Induced Epithelial-Mesenchymal Transition.
Lv B; Ma L; Tang W; Huang P; Yang B; Wang L; Chen S; Gao Q; Zhang S; Xia J
Cell Physiol Biochem; 2018; 48(1):158-172. PubMed ID: 30001540
[TBL] [Abstract][Full Text] [Related]
4. Liensinine inhibits progression of intrahepatic cholangiocarcinoma by regulating TGF-β1 /P-smad3 signaling through HIF-1a.
Zhu X; Bao W; Xie X; Chen B; Li R; Zhao J; Wu L; Yu Z; Li S; Zhu Q; Chen G; Li J
Mol Carcinog; 2024 Apr; 63(4):772-784. PubMed ID: 38289159
[TBL] [Abstract][Full Text] [Related]
5. Lnc-LFAR1 affects intrahepatic cholangiocarcinoma proliferation, invasion, and EMT by regulating the TGFβ/Smad signaling pathway.
Chen C; Li H; Wang X; Wang L; Zeng Q
Int J Clin Exp Pathol; 2019; 12(7):2455-2461. PubMed ID: 31934072
[TBL] [Abstract][Full Text] [Related]
6. SQSTM1/p62 in intrahepatic cholangiocarcinoma promotes tumor progression via epithelial-mesenchymal transition and mitochondrial function maintenance.
Chen J; Gao Z; Li X; Shi Y; Tang Z; Liu W; Zhang X; Huang A; Luo X; Gao Q; Ding G; Song K; Zhou J; Fan J; Fu X; Ding Z
Cancer Med; 2023 Jan; 12(1):459-471. PubMed ID: 35676831
[TBL] [Abstract][Full Text] [Related]
7. Blocking ERK1/2 signaling impairs TGF-β1 tumor promoting function but enhances its tumor suppressing role in intrahepatic cholangiocarcinoma cells.
Sritananuwat P; Sueangoen N; Thummarati P; Islam K; Suthiphongchai T
Cancer Cell Int; 2017; 17():85. PubMed ID: 28959141
[TBL] [Abstract][Full Text] [Related]
8. ETV4 facilitates proliferation, migration, and invasion of liver cancer by mediating TGF-β signal transduction through activation of B3GNT3.
Zhou Z; Wu B; Chen J; Shen Y; Wang J; Chen X; Fei F; Li L
Genes Genomics; 2023 Nov; 45(11):1433-1443. PubMed ID: 37523127
[TBL] [Abstract][Full Text] [Related]
9. LKB1 inhibits intrahepatic cholangiocarcinoma by repressing the transcriptional activity of the immune checkpoint PD-L1.
Liu Z; Li S; Zeng J; Zhou X; Li H; Liu X; Li F; Jiang B; Zhao M; Ma T
Life Sci; 2020 Sep; 257():118068. PubMed ID: 32653521
[TBL] [Abstract][Full Text] [Related]
10. Mortalin promotes cell proliferation and epithelial mesenchymal transition of intrahepatic cholangiocarcinoma cells in vitro.
Kang Q; Cai JB; Dong RZ; Liu LX; Zhang C; Zhang PF; Zou H; Xie N; Zhang L; Zhang XY; Song ZJ; Dong ZR; Hu MY; Huang XY; Zhang XW; Ke AW; Shi GM
J Clin Pathol; 2017 Aug; 70(8):677-683. PubMed ID: 28096273
[TBL] [Abstract][Full Text] [Related]
11. WAVE3 Induces EMT and Promotes Migration and Invasion in Intrahepatic Cholangiocarcinoma.
Zhu Z; Chen W; Yin X; Lai J; Wang Q; Liang L; Wang W; Wang A; Zheng C
Dig Dis Sci; 2016 Jul; 61(7):1950-60. PubMed ID: 26971088
[TBL] [Abstract][Full Text] [Related]
12. HSPB8 promoted intrahepatic cholangiocarcinoma progression by enhancing epithelial-mesenchymal transition and autophagy.
Shu B; Zhou Y; Liang Q; He C; Li F
Exp Mol Pathol; 2021 Dec; 123():104691. PubMed ID: 34606781
[TBL] [Abstract][Full Text] [Related]
13. SHCBP1 promotes synovial sarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with poor prognosis.
Peng C; Zhao H; Song Y; Chen W; Wang X; Liu X; Zhang C; Zhao J; Li J; Cheng G; Wu D; Gao C; Wang X
J Exp Clin Cancer Res; 2017 Oct; 36(1):141. PubMed ID: 29020987
[TBL] [Abstract][Full Text] [Related]
14. S100A11 promotes cell proliferation via P38/MAPK signaling pathway in intrahepatic cholangiocarcinoma.
Zhang MX; Gan W; Jing CY; Zheng SS; Yi Y; Zhang J; Xu X; Lin JJ; Zhang BH; Qiu SJ
Mol Carcinog; 2019 Jan; 58(1):19-30. PubMed ID: 30182496
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of microRNA-29b inhibits epithelial-mesenchymal transition and angiogenesis of colorectal cancer through the ETV4/ERK/EGFR axis.
Leng Y; Chen Z; Ding H; Zhao X; Qin L; Pan Y
Cancer Cell Int; 2021 Jan; 21(1):17. PubMed ID: 33407520
[TBL] [Abstract][Full Text] [Related]
16. SHH/GLI2-TGF-β1 feedback loop between cancer cells and tumor-associated macrophages maintains epithelial-mesenchymal transition and endoplasmic reticulum homeostasis in cholangiocarcinoma.
Chen Z; Li H; Li Z; Chen S; Huang X; Zheng Z; Qian X; Zhang L; Long G; Xie J; Wang Q; Pan W; Zhang D
Pharmacol Res; 2023 Jan; 187():106564. PubMed ID: 36423790
[TBL] [Abstract][Full Text] [Related]
17. [E26 transformation-specific variant 4 promotes sorafenib and cisplatin resistance in hepatocellular carcinoma cells
Xiaohui C; Xin LI; Dehua WU
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Aug; 39(8):875-882. PubMed ID: 31511205
[TBL] [Abstract][Full Text] [Related]
18. miR-424-5p represses the metastasis and invasion of intrahepatic cholangiocarcinoma by targeting ARK5.
Wu J; Yang B; Zhang Y; Feng X; He B; Xie H; Zhou L; Wu J; Zheng S
Int J Biol Sci; 2019; 15(8):1591-1599. PubMed ID: 31360102
[TBL] [Abstract][Full Text] [Related]
19. AZGP1 activation by lenvatinib suppresses intrahepatic cholangiocarcinoma epithelial-mesenchymal transition through the TGF-β1/Smad3 pathway.
Deng L; Bao W; Zhang B; Zhang S; Chen Z; Zhu X; He B; Wu L; Chen X; Deng T; Chen B; Yu Z; Wang Y; Chen G
Cell Death Dis; 2023 Sep; 14(9):590. PubMed ID: 37669935
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of FGFR3 inhibits the proliferation, migration and invasion of intrahepatic cholangiocarcinoma.
Chen YH; Yang SH; Liu LX; Hu S; Wang XJ; Liao ZJ; Huan YF; He K; Zhang XW
Dig Liver Dis; 2023 Mar; 55(3):400-406. PubMed ID: 35999136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
